{"version":"1.0","type":"rich","width":"560px","height":"140px","title":"Frontline Therapy for transplant ineligible patients: the European perspective","url":"https:\/\/www.myelomasociety.org\/frontline-therapy-for-transplant-ineligible-patients-the-european-perspective\/","author_name":"IMSound","author_url":"https:\/\/www.myelomasociety.org","thumbnail_url":"https:\/\/www.myelomasociety.org\/wp-content\/uploads\/2024\/07\/IMSound-Logo-only-v2.png","html":"<iframe width=\"560px\" height=\"140px\" src=\"https:\/\/www.myelomasociety.org\/frontline-therapy-for-transplant-ineligible-patients-the-european-perspective\/?standalonePlayer\"><\/iframe>"}